Menu Back to 06

Track 6: Preclinical Development and Early-Phase Clinical Research

Preclinical and early-phase clinical research provides initial dosing and safety data for new drugs. This track focuses on the latest strategies used in early-stage compound selection, updates on safety considerations for both drugs and biologics, how PK/PD affects dosing strategies, and methods to improve data quality and integrity for proper downstream decision-making.

Sessions in PreClinical Dev-EarlyPhaseCR

View Other Tracks

Registration Rates

Back to DIA 2022

Back to